Prolotherapy with 12.5% dextrose to treat temporomandibular joint dysfunction (TMD)
Journal: International Journal of Oral and Craniofacial Science (Vol.5, No. 1)Publication Date: 2019-02-26
Authors : Ehab Shehata;
Page : 015-019
Keywords : Temporomandibular disorders; Atypical swallowing; Dyslalia; Adult subjects; TMD; TMJ;
Abstract
Introduction: Temporomandibular joint dysfunction (TMD) is a collective term used to describe a complex and multifactorial disorders of the orofacial region. Symptoms commonly associated with TMD include TMJ pain, limited mandibular movement or locking and painful clicking or popping sounds. Most of patients diagnosed with TMD are initially treated conservatively. Failure of such conservatism poses a great challenge for the treating physician. Prolotherapy has been used successfully in many joints in the body by orthopedics and spinal surgeons. Injection prolotherapy has also been used in management of weakening tendons or ligaments in head and neck.
Other Latest Articles
- Aging: Basic Concept
- ROLE OF RELIGIOUS ORIENTATION AND MENTAL HEALTH ON CRITICAL THINKING AMONG ACADEMICIANS
- Association of Preeclampsia with Obesity
- Proposal: Lean Model for Continuous Improvement as a Cost Reduction Strategy, ¨SME: SL Service Automotive Mechanical Engineering¨
- The Management of Human Talent as a Key Factor in Quality Processes under IATF 16949 Standard in a Company in the State of Tlaxcala
Last modified: 2019-05-02 15:06:25